JPMORGAN CHASE & CO

Position in SLS — SELLAS Life Sciences Group, Inc.

CIK 19617 NEW YORK, NY

Position in SLS

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$1,477,991

+$1,131,876 QoQ

Shares Held

100,135

+22.4% QoQ

Ownership

0.050%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#52

of 192 holders

Holding Since

Jun 2021

13 quarters on record

Voting authority Sole 18% Shared 0% None 82%

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,940,196,194 across 425 Biotechnology names. SLS ranks #166 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	6,517,600	$3,237,487,438
2	REGN	Regeneron Pharmaceuticals, Inc.	3,774,199	$2,353,364,036
3	INSM	INSMED Inc	10,428,170	$1,111,851,478
4	ALNY	Alnylam Pharmaceuticals, Inc.	2,675,517	$805,410,876
5	RVMD	Revolution Medicines, Inc.	3,298,066	$617,661,794
6	RYTM	Rhythm Pharmaceuticals, Inc.	2,652,746	$294,534,385
7	JAZZ	Jazz Pharmaceuticals plc	1,160,786	$279,714,596
8	QURE	uniQure N.V.	4,867,755	$224,208,791

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,477,991	100,135	+22.4%	Shares	Defined	2026-08-12
2026-03-31	$346,115	81,824	+65.4%	Shares	Defined	2026-05-13
2025-12-31	$186,535	49,479	+21.5%	Shares	Defined	2026-02-11
2025-09-30	$65,562	40,722	-34.2%	Shares	Defined	2025-11-07
2025-06-30	$135,543	61,892	+969.1%	Shares	Defined	2025-08-12
2024-09-30	$7,236	5,789	-5.0%	Shares	Defined	2024-12-26
2024-03-31	$6,152	6,092	-37.8%	Shares	Defined	2024-12-26
2023-12-31	$10,380	9,793	+142.8%	Shares	Defined	2024-12-26
2023-09-30	$6,615	4,034	+101.7%	Shares	Defined	2023-11-14
2023-06-30	$3,140	2,000	-43.7%	Shares	Defined	2023-08-11
2022-09-30	$7,171	3,550	0.0%	Shares	Defined	2022-11-14
2022-06-30	$7,916	3,550	+305.3%	Shares	Defined	2022-08-11
2021-06-30	$9,723	876	—	Shares	Defined	2021-08-12
No filing history on record for this holder in this stock.